not tagged
not tagged
['aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)']
fabulous presentation by hartmut dohner regarding updated 2022 eln aml guidelines. not clear to me that idh1 should be considered a baseline actionable mutation as it is unknown whether aza/ivo &gt; aza/ven. ph3 control was not soc #eha2022 
Clinical haematologist and haematopathologist in Sydney, Australia.